168 related articles for article (PubMed ID: 2906108)
21. Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue.
Küng W; Bechtel E; Geyer E; Salokangas A; Preisz J; Huber P; Torhorst J; Jungmann RA; Talmadge K; Eppenberger U
FEBS Lett; 1977 Oct; 82(1):102-6. PubMed ID: 199454
[No Abstract] [Full Text] [Related]
22. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
23. [Changes in cyclic nucleotide metabolism in compensatory adrenal hypertrophy (following unilateral adrenalectomy)].
Iudaev NA; Afinogenova SA; Zhukova TV
Probl Endokrinol (Mosk); 1982; 28(6):59-66. PubMed ID: 6130520
[TBL] [Abstract][Full Text] [Related]
24. Changes of [3H]cyclic adenosine monophosphate binding in the gerbil brain following transient cerebral ischemia: an autoradiographic study and investigation of the effects of vinconate and pentobarbital.
Araki T; Kanai Y; Murakami F; Kato H; Kogure K
Res Exp Med (Berl); 1993; 193(1):57-64. PubMed ID: 8383351
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
26. Effects of topical methylene blue on cyclic GMP level, blood flow, and O2 consumption in focal cerebral ischaemia.
Wei HM; Tse J; Chi OZ; Weiss HR
Neurol Res; 1994 Dec; 16(6):449-55. PubMed ID: 7708136
[TBL] [Abstract][Full Text] [Related]
27. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
28. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
29. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
30. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
31. Function of calmodulin in postsynaptic densities. I. Presence of a calmodulin-activatable cyclic nucleotide phosphodiesterase activity.
Grab DJ; Carlin RK; Siekevitz P
J Cell Biol; 1981 Jun; 89(3):433-9. PubMed ID: 6265466
[TBL] [Abstract][Full Text] [Related]
32. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
[TBL] [Abstract][Full Text] [Related]
33. Cyclic AMP and cyclic GMP in epidermal physiology and pathophysiology.
Voorhees JJ; Duell EA; Creehan P; Stawiski M; Harrell ER
Curr Probl Dermatol; 1976; 6():107-53. PubMed ID: 8278
[TBL] [Abstract][Full Text] [Related]
34. Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.
Tertov VV; Orekhov AN; Grigorian GYu ; Kurennaya GS; Kudryashov SA; Tkachuk VA; Smirnov VN
Tissue Cell; 1987; 19(1):21-8. PubMed ID: 2882618
[TBL] [Abstract][Full Text] [Related]
35. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
Lochner A; Genade S; Tromp E; Opie L; Moolman J; Thomas S; Podzuweit T
Mol Cell Biochem; 1998 Sep; 186(1-2):169-75. PubMed ID: 9774198
[TBL] [Abstract][Full Text] [Related]
36. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat.
van Staveren WC ; Markerink-van Ittersum M ; Steinbusch HW; de Vente J
Brain Res; 2001 Jan; 888(2):275-286. PubMed ID: 11150485
[TBL] [Abstract][Full Text] [Related]
37. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
Onali P; Schwartz JP; Hanbauer I; Costa E
Biochim Biophys Acta; 1981 Jul; 675(2):285-92. PubMed ID: 6268187
[TBL] [Abstract][Full Text] [Related]
38. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
J Ocul Pharmacol Ther; 2000 Aug; 16(4):317-22. PubMed ID: 10977127
[TBL] [Abstract][Full Text] [Related]
39. Effects of Ca2+ and calmodulin on cyclic nucleotide metabolism in neurosecretosomes isolated from ox neurohypophyses.
Dartt DA; Torp-Pedersen C; Thorn NA
Brain Res; 1981 Jan; 204(1):121-8. PubMed ID: 6113872
[TBL] [Abstract][Full Text] [Related]
40. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
